ABG Analytics logo
Get updates

Celgene Corp (NASDAQ: CELG)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 07/19/2019
Closing price: 90.20
Support price level: N/A
Resistance price level: $93.25
Relative strength index (14-day RSI) 34.5
Beta 1.30
  • CELG is one of this month's worst performers with a return of -8.1%, underperforming 90 percent of stocks in the S&P-100.

  • Volatility is forecast to fall over the next month.

  • CELG is above its 200-day moving average, providing a measure of support for long positions.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$59.21 $98.91 82.0%
200 day 50 day 20 day 10 day
$85.87 $94.53 $92.92 $92.03
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
31.2% 21.7% 25.7% 29.4%
There is an estimated 5% probability that the stock price of Celgene Corp will fall by more than:
  • 7.0% in the next week.

  • 16.6% in the next month.

  • 68.2% in the next year.